Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Ranbaxy Laboratories has put all shipments on hold at plants producing active pharmaceutical ingredients in Toansa and Dewas, India. The firm says it voluntarily made the decision to examine processes and controls at the facilities. Products from the two sites have been banned from the U.S. since January when FDA found manufacturing deficiencies at the plants. FDA earlier banned products made at Ranbaxy’s plant in Mohali, India. Japanese drug firm Daiichi Sankyo is Ranbaxy’s majority owner.
This article has been sent to the following recipient: